Cardiac and vascular serious adverse events following tixagevimab-cilgavimab - Author's reply

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

Cardiac and vascular serious adverse events following tixagevimab-cilgavimab - Author's reply

Maselkar, Sheetal; Kiazand, Alexandre; Templeton, Alison; Montgomery, Hugh; Esser, Mark T; (2023) Cardiac and vascular serious adverse events following tixagevimab-cilgavimab - Author's reply. The Lancet Respiratory Medicine , 11 (1) e7-e8. 10.1016/S2213-2600(22)00450-7. Green open access

Preview

Text
main (7).pdf - Published Version
Download (184kB) | Preview

Type:	Article
Title:	Cardiac and vascular serious adverse events following tixagevimab-cilgavimab - Author's reply
Location:	England
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1016/S2213-2600(22)00450-7
Publisher version:	https://doi.org/10.1016/S2213-2600(22)00450-7
Language:	English
Additional information:	This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords:	Antibodies, Monoclonal, Humans
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Experimental and Translational Medicine
URI:	https://discovery.ucl.ac.uk/id/eprint/10162443

Downloads since deposit

0Downloads

Download activity - last month

Download activity - last 12 months

Downloads by country - last 12 months

Archive Staff Only

View Item